期刊文献+

坦度螺酮联合西酞普兰治疗伴焦虑症状的抑郁症对照研究 被引量:1

A Comparative Study of Tandospirone Combined Citalopram in Treatment of Depression with Anxiety
暂未订购
导出
摘要 目的探讨坦度螺酮联合西酞普兰治疗伴有焦虑症状的抑郁症疗效。方法将56例伴有焦虑症状的抑郁症患者随机分成两组,各28例。治疗组在用西酞普兰基础上联合使用坦度螺酮治疗,对照组仅用西酞普兰治疗,疗程6周。采用汉密尔顿抑郁量表(HAMD)、汉密尔顿焦虑量表(HAMA)评定疗效,采用药物不良反应量表(TESS)于治疗6周末评定不良反应。结果 6周末治疗组HAMD和HAMA评分低于对照组。两组不良反应无显著差异。结论坦度螺酮联合西酞普兰治疗伴有焦虑症状的抑郁症的疗效优于单用西酞普兰。 Objective To study the efficacy of tandospirone combined citalopram on depression with anxiety.Methods A total of 56 patients who met with the criteria of CCMD-3 for depression with anxiety were randomly divided into tandospirone combined citalopram group and citalopram group with the treatment of 6 weeks.The efficacy was evaluated with Hamilton Rating Scale for depression(HAMD) and Hamilton Rating Scale for anxiety(HAMA).The side effects were evaluated with Treatment Emergent Symptoms Scale(TESS).Results The reduce rate of mean score of HAMD and HAMA in intervention group was significantly higher than that of control group.Two groups of side effects was similar.Conclusion Tandospirone combined citalopram has better effect in treatment of depression with anxiety.
作者 王晶 刘晶洁
出处 《中国医药指南》 2012年第30期407-408,共2页 Guide of China Medicine
关键词 坦度螺酮 西酞普兰 抑郁症 焦虑症状 Tandospirone Citalopram Depression Anxiety
  • 相关文献

参考文献5

二级参考文献28

  • 1[5]Murasaki M. Overview of serotonin 1A receptor selective agents in anxiety disorders - the developmental situation in Japan. Int Rev Psychiatry, 1995, 7:105~113
  • 2[6]Murasaki M, Miura S. Future of 5-HT1A receptor agonists (aryl-piperazine derivatives). Prog Neuro-Psychopharmacol &Biol Psychiatry, 1992, 16:833~845
  • 3[7]Matsumoto M, Yoshioka M. Possible involvment of serotonin receptors in anxiety disorders. Nippon Yakurigahu Zasshi, 2000,115 (Suppl.): S39~S44
  • 4[8]Shimizu H, Kariai N, Hirose A, et al. Interaction of SM-3997with serotonin receptors in rat brain. Jpn J Pharmacol, 1998,46:311~314
  • 5[9]Shimizu H, Tatsuno T, Tanaka H, et al. Serotonergic mechanism in anxiolytic effect of tandospirone in the vogel conflict test.Jpn J Pharmacol, 1992, 59:105~122
  • 6[10]Barradell LB, Fitton A. Tandospirone. CNC Drug, 1996, 5:147~153
  • 7[11]Lucki I. Behavioral studies of serotonin receptor agonists as antidepressant drug. J Clin Psychiatry, 1991, 52 (Suppl.): S24~S31
  • 8[13]Sumiyoshi T, Matsui M, Yamashita I, et al. The effect of tandospirone, a serotonin1A agonist, on memory function in schizophrenia. Bio Psychiatry, 2001, 49:861~868
  • 9[14]Tamai H, Komaki G, Kubota S, et al. The clinical efficacy of a 5-HT1A agonists, SM-1997, in the treatment of bulimia. IntJ Obesity, 1990, 14:289~292
  • 10[15]Yoshida K, Sugita T, Higuchi H, et al. Effect of tandospirone on tardive dyskinesia and parkinsonian symptoms. Eur Psychiatry, 1998, 13 (8): 421~422

共引文献104

同被引文献30

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部